IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
77 hedge funds and large institutions have $56.5M invested in IVERIC bio, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 34 reducing their positions, and 35 closing their positions.
867% more call options, than puts
Call options by funds: $1.31M | Put options by funds: $136K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less funds holding
Funds holding: 100 → 77 (-23)
42% less capital invested
Capital invested by funds: $97.4M → $56.5M (-$40.9M)
56% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 34
63% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$6.54M |
| 2 |
D.E. Shaw & Co
New York
|
+$2.56M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$658K |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$486K |
| 5 |
ECM
Element Capital Management
New York
|
+$437K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.68M |
| 2 |
BlackRock
New York
|
-$3.84M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$1.73M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.57M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.46M |
ISEE Hedge Fund Activity: Q2 2017 in Review
77 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2017, worth a combined $56.5M — down 42% from $97.4M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of ISEE and 13 opened new positions — a net loss of 22 holders — while 34 trimmed existing stakes and 15 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $6.54M. The largest seller was Morgan Stanley, cutting an estimated $5.68M.
- 77 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2017, down from 100 in Q1 2017.
- Funds reported $56.5M of IVERIC bio, Inc. Common Stock stock for Q2 2017, down 42% quarter-over-quarter.
- 13 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2017 and 35 closed out, a net change of -22 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q2 2017 was Armistice Capital, an estimated $6.54M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q2 2017 was Morgan Stanley, an estimated $5.68M sold.
Based on aggregated 13F filings for Q2 2017.